Substance / Medication

Carboprost tromethamine

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Surgical and Reproductive Outcomes after Hysteroscopic Removal of Retained Products of Conception: A Systematic Review and Meta-analysis.
Vitale Salvatore Giovanni, Parry John Preston, Carugno Jose et al. · J Minim Invasive Gynecol · 2021
PMID: 33166659Meta-Analysis
Medical management of induced and incomplete first-trimester abortion by non-physicians in low- and middle-income countries: A systematic review and meta-analysis of randomized controlled trials.
Kristiansen Marianne Bogen, Shayo Benjamin C, Philemon Rune et al. · Acta Obstet Gynecol Scand · 2021
PMID: 33724458Meta-Analysis
Availability, accessibility and utilization of post-abortion care in Sub-Saharan Africa: A systematic review.
Izugbara Chimaraoke, Wekesah Frederick Murunga, Sebany Meroji et al. · Health Care Women Int · 2020
PMID: 31855511Meta-Analysis
Advances in the management of early pregnancy loss.
Henkel Andrea, Shaw Kate A · Curr Opin Obstet Gynecol · 2018
PMID: 30299321Meta-Analysis
Medical treatments for incomplete miscarriage.
Kim Caron, Barnard Sharmani, Neilson James P et al. · Cochrane Database Syst Rev · 2017
PMID: 28138973Meta-AnalysisFull text (PMC)
Second-trimester postabortion care for ruptured membranes, fetal demise, and incomplete abortion.
Mark Alice G, Edelman Alison, Borgatta Lynn · Int J Gynaecol Obstet · 2015
PMID: 25660084Meta-Analysis
Effectiveness of Remimazolam on Preventing Adverse Reactions Caused by Carboprost Tromethamine During Cesarean Section.
Fan Jianjun, Zhang Zhiguo, Wang Jie et al. · Clin Ther · 2025
PMID: 39490239RCT

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Carboprost trometamol (substance)
SNOMED CT
109058009
UMLS CUI
C0054721

Clinical Data

This intervention maps to 4 entities in the Ltrl knowledge graph.

4
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.